BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Business

  Sosei Group: Notice of Change of Corporate Name to Nxera Pharma and Change of Location of Head Office

  Sosei Group Corporation, announces that at a meeting held on 15 February 2024, its Board of Directors resolved to change the corporate names of the Company and its subsidiaries and the location of the head office of the Company.

  February 15, 2024

   · 

  6 min read
• Business

  Travere Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results

  Travere Therapeutics, Inc. reported its fourth quarter and full year 2023 financial results and provided a corporate update.

  February 15, 2024

   · 

  23 min read
• Business

  T2 Biosystems Announces Preliminary Fourth Quarter and Full Year 2023 Financial Results

  T2 Biosystems, Inc., a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, announced preliminary unaudited financial and operational results for the fourth quarter and full year ended December 31, 2023.

  February 15, 2024

   · 

  7 min read
• Business

  10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024

  10x Genomics, Inc., a leader in single cell and spatial biology, reported financial results for the fourth quarter and full year ended December 31, 2023 and provided outlook for 2024.

  February 15, 2024

   · 

  11 min read
• Business

  Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024

  Amylyx Pharmaceuticals, Inc. will report its fourth quarter and full year 2023 financial results on Thursday, February 22, 2024.

  February 15, 2024

   · 

  1 min read
• Business

  PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

  PacBio announced financial results for the quarter and fiscal year ended December 31, 2023.

  February 15, 2024

   · 

  19 min read
• Business

  AtriCure Reports Fourth Quarter 2023 and Full Year 2023 Financial Results

  AtriCure, Inc., a leading innovator in surgical treatments and therapies for atrial fibrillation, left atrial appendage management and post-operative pain management, announced fourth quarter 2023 and full year 2023 financial results.

  February 15, 2024

   · 

  12 min read
• Biotech Beach

  Modular Medical Announces Proposed Public Offering - February 15, 2024

  Modular Medical, Inc. announced that it has commenced an underwritten public offering of shares of its common stock.

  February 15, 2024

   · 

  4 min read
• Pharm Country

  BD to Present at Investor Healthcare Conferences - February 15, 2024

  BD, a leading global medical technology company, announced that it will present at the following healthcare conferences.

  February 15, 2024

   · 

  1 min read
• Pharm Country

  Inventiva reports preliminary 2023 fiscal year financial Information¹ and provides an update on its clinical trial NATiV3

  Inventiva reported certain preliminary unaudited financial results as of and for the full year ended December 31, 2023, including cash, cash equivalents, and revenues, and provided an update on its clinical trial NATiV3.

  February 15, 2024

   · 

  20 min read